Business · 02/12/2004Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Equine Protozoal Myeloencephalitis
Summary
The FDA is amending its regulations to reflect the approval of a new animal drug application by Animal Health Pharmaceuticals, LLC, which allows for the veterinary prescription use of an oral suspension of sulfadiazine and pyrimethamine to treat equine protozoal myeloencephalitis.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →